Paper10981663
Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR.
Willemsen RA and 6 others. Gene Ther, 2000. Cited by 131 papers, by iCite.
Cite this record
ConductScience Library. Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR. Papers, record 10981663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10981663
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Transfer Techniques | Major topic |
| Genetic Therapy | Major topic |
| Receptors, Antigen, T-Cell, alpha-beta | Major topic |
| T-Lymphocytes | Major topic |
| Chimera | |
| Clone Cells | |
| Genetic Vectors | |
| Granulocyte-Macrophage Colony-Stimulating Factor | |
| Humans | |
| Interferon-gamma | |
| Melanoma | |
| Protein Engineering | |
| Retroviridae | |
| Tumor Necrosis Factor-alpha |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1833767 | T-cell and basophil activation through the cytoplasmic tail of T-cell-receptor zeta family proteins. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/1833767 | PubMed |
| 2 | 10680014 | Functional balance between T cell chimeric receptor density and tumor associated antigen density: CTL mediated cytolysis and lymphokine production. | Gene Ther | 2000 | https://conductscience.org/library/papers/10680014 | PubMed |
| 3 | 8499079 | The roles of CD8 in cytotoxic T lymphocyte function. | Immunol Today | 1993 | https://conductscience.org/library/papers/8499079 | PubMed |
| 4 | 9894898 | Display of functional alphabeta single-chain T-cell receptor molecules on the surface of bacteriophage. | J Immunol Methods | 1998 | https://conductscience.org/library/papers/9894898 | PubMed |
| 5 | 8376761 | Clustered CD3/TCR complexes do not transduce activation signals after bispecific monoclonal antibody-triggered lysis by cytotoxic T lymphocytes via CD3. | J Immunol | 1993 | https://conductscience.org/library/papers/8376761 | PubMed |
| 6 | 9573255 | High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments. | J Virol | 1998 | https://conductscience.org/library/papers/9573255 | PubMed |
| 7 | 1565634 | HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1565634 | PubMed |
| 8 | 1386349 | Optimization of culture conditions for activation and large-scale expansion of human T lymphocytes for bispecific antibody-directed cellular immunotherapy. | Int J Cancer | 1992 | https://conductscience.org/library/papers/1386349 | PubMed |
| 9 | 10318939 | Selection of functional T cell receptor mutants from a yeast surface-display library. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10318939 | PubMed |
| 10 | 1598575 | High-efficiency expression and solubilization of functional T cell antigen receptor heterodimers. | Science | 1992 | https://conductscience.org/library/papers/1598575 | PubMed |
| 11 | 1840703 | A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. | Science | 1991 | https://conductscience.org/library/papers/1840703 | PubMed |
| 12 | 9677202 | Fidelity of T cell activation through multistep T cell receptor zeta phosphorylation. | Science | 1998 | https://conductscience.org/library/papers/9677202 | PubMed |
| 13 | 9973498 | Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. | J Immunol | 1999 | https://conductscience.org/library/papers/9973498 | PubMed |
| 14 | 7674333 | Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody. | J Natl Cancer Inst | 1995 | https://conductscience.org/library/papers/7674333 | PubMed |
| 15 | 7899083 | A transient three-plasmid expression system for the production of high titer retroviral vectors. | Nucleic Acids Res | 1995 | https://conductscience.org/library/papers/7899083 | PubMed |
| 16 | 8810254 | Phenotypic analysis of antigen-specific T lymphocytes. | Science | 1996 | https://conductscience.org/library/papers/8810254 | PubMed |
| 17 | 3264384 | Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. | N Engl J Med | 1988 | https://conductscience.org/library/papers/3264384 | PubMed |
| 18 | 8752936 | Single chain Ig/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity. | J Immunol | 1996 | https://conductscience.org/library/papers/8752936 | PubMed |
| 19 | 9930320 | A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes. | Gene Ther | 1998 | https://conductscience.org/library/papers/9930320 | PubMed |
| 20 | 6197484 | Rapid expansion of human cytotoxic T cell clones: growth promotion by a heat-labile serum component and by various types of feeder cells. | J Immunol Methods | 1984 | https://conductscience.org/library/papers/6197484 | PubMed |
Cited by62
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 131 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42777048 | Computational design of optimized and preferentially paired human TCR constant regions for improved T cell function. | Sci Adv | 2026 | https://conductscience.org/library/papers/42777048 | PubMed |
| 42056218 | De novo engineered disulfide bond supersedes native interchain linkage to enhance TCR pairing and anti-tumor efficacy in T cell therapy. | Cell Mol Immunol | 2026 | https://conductscience.org/library/papers/42056218 | PubMed |
| 41050431 | Enhanced solid tumor cell targeting by a neoepitope-encoding oncolytic measles virus combined with CAR therapy. | Mol Ther Oncol | 2025 | https://conductscience.org/library/papers/41050431 | PubMed |
| 40910564 | Divergent on-target off-tumor effects by CAR T and CAR NK cells suggest different efficacy and safety of cell therapies. | Oncoimmunology | 2025 | https://conductscience.org/library/papers/40910564 | PubMed |
| 39813621 | Current developments in T-cell receptor therapy for acute myeloid leukemia. | Blood Adv | 2025 | https://conductscience.org/library/papers/39813621 | PubMed |
| 39172012 | TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer. | Cancer Discov | 2024 | https://conductscience.org/library/papers/39172012 | PubMed |
| 36949949 | Current and future concepts for the generation and application of genetically engineered CAR-T and TCR-T cells. | Front Immunol | 2023 | https://conductscience.org/library/papers/36949949 | PubMed |
| 36834542 | Efficient Redirection of NK Cells by Genetic Modification with Chemokine Receptors CCR4 and CCR2B. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36834542 | PubMed |
| 36338746 | TCR mimic compounds for pHLA targeting with high potency modalities in oncology. | Front Oncol | 2022 | https://conductscience.org/library/papers/36338746 | PubMed |
| 35432319 | Emerging Strategies in TCR-Engineered T Cells. | Front Immunol | 2022 | https://conductscience.org/library/papers/35432319 | PubMed |
| 35309357 | Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects. | Front Immunol | 2022 | https://conductscience.org/library/papers/35309357 | PubMed |
| 33670139 | Adoptive Immunotherapy beyond CAR T-Cells. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33670139 | PubMed |
| 32570906 | Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy. | Cells | 2020 | https://conductscience.org/library/papers/32570906 | PubMed |
| 32429338 | T Cells Expressing a TCR-Like Antibody Selected Against the Heteroclitic Variant of a Shared MAGE-A Epitope Do Not Recognise the Cognate Epitope. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32429338 | PubMed |
| 31852498 | Targeting cancers through TCR-peptide/MHC interactions. | J Hematol Oncol | 2019 | https://conductscience.org/library/papers/31852498 | PubMed |
| 31355495 | T cell receptor-based cancer immunotherapy: Emerging efficacy and pathways of resistance. | Immunol Rev | 2019 | https://conductscience.org/library/papers/31355495 | PubMed |
| 30836996 | Impact of c-MYC expression on proliferation, differentiation, and risk of neoplastic transformation of human mesenchymal stromal cells. | Stem Cell Res Ther | 2019 | https://conductscience.org/library/papers/30836996 | PubMed |
| 28405508 | Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities. | Oncoimmunology | 2017 | https://conductscience.org/library/papers/28405508 | PubMed |
| 28392558 | The challenges of solid tumor for designer CAR-T therapies: a 25-year perspective. | Cancer Gene Ther | 2017 | https://conductscience.org/library/papers/28392558 | PubMed |
| 27028870 | An optimized single chain TCR scaffold relying on the assembly with the native CD3-complex prevents residual mispairing with endogenous TCRs in human T-cells. | Oncotarget | 2016 | https://conductscience.org/library/papers/27028870 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD247 | 919 | PubTator's text mining | https://conductscience.org/library/genes/919 | NCBI Gene |
| HLA-C | 3107 | PubTator's text mining | https://conductscience.org/library/genes/3107 | NCBI Gene |
| TRAJ60 | 28695 | PubTator's text mining | https://conductscience.org/library/genes/28695 | NCBI Gene |
| TRBV20OR9-2 | 6962 | PubTator's text mining | https://conductscience.org/library/genes/6962 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10981663
GET https://conductscience.org/api/papers/v1/10981663/references?page=2